Below is a comprehensive archive of press releases from MSF USA. Use the options in the boxes below to filter results based on your preferences.

MSF has released a list of important stories that had an impact on people’s ability to access needed drugs, diagnostics, and vaccines in developing countries in 2011.

More >

Thousands of people with Chagas disease will go untreated in coming months due to a shortage of benznidazole, the first-line drug used in most endemic countries.

More >

Geneva, May 17, 2010 – A World Health Assembly (WHA) resolution on Chagas disease control and elimination, to be adopted this week, is a step in the right direction but does not go far enough to fully tackle the disease since it focuses only on prevention, the international medial humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and the Drugs for Neglected Disease initiative(DNDi) said today.

More >

Madrid, July 9, 2009 — The international medical humanitarian organization Doctors Without Borders/Medecins Sans Frontieres (MSF) today launched a campaign to raise awareness of the parasitic disease Chagas. MSF is calling on countries where the disease is endemic to stop neglecting the disease by moving beyond prevention activities to increased diagnosis and treatment.

More >

Barcelona/Geneva, New York, May, 19, 2009 – The World Health Organization (WHO) has cut short its annual health ministers meeting because of influenza A (H1N1) preparations and has postponed discussions about Chagas disease. Much needed progress in diagnosing and treating people for this neglected disease must not be further delayed, warned the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today.

More >

Geneva/New York, February 23, 2009 — MSF and the Drugs for Neglected Diseases initiative (DNDi) called today for more sustainable funding for research and development (R&D) to tackle deadly, yet neglected diseases, such as sleeping sickness, visceral leishmaniasis, and Chagas disease, that affect millions of people around the world.

More >

Rio de Janeiro, April 17, 2008 – Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the launch in Brazil of a new drug against P. Falciparum, the most dangerous type of malaria. Developed by DNDi (Drugs for Neglected Diseases Initiative) in partnership with Farmanguinhos/Fiocruz, ASMQ is the first drug against malaria that combines artesunate (AS) and mefloquine (MQ) in one fixed dose. ASMQ is an important additional tool for better treatment for a disease that continues to kill over one million people each year globally, and kills a child every 30 seconds.

More >

New York, NY, October 31, 2007 - In a study published today in the inaugural issue of PLoS Neglected Tropical Diseases, Doctors Without Borders/Médecins Sans Frontières (MSF) medical teams detail a dramatic increase in visceral leishmaniasis, also known as kala azar, in the Bakool region of south-central Somalia. The current conflict in Somalia and the lack of health infrastructure makes it both difficult to address the problem and to assess the true magnitude of the impact of the disease.

More >

Geneva/Mexico City, November 16, 2004 - The current system for health research and development is failing to bring the benefits of medical progress to the poor, according to the medical humanitarian organization Doctors Without Borders/Medecins Sans Frontieres (MSF) on the opening day of the Ministerial Summit on Health Research, "Bridging the Know-Do Divide to Achieve the Millennium Development Goals," in Mexico City.

More >

Santa Cruz de la Sierra, Bolivia, November 13, 2003 - As leaders convene at the XIII Iberoamerican Summit in Santa Cruz, Bolivia, the international medical humanitarian aid organization Doctors Without Borders/Médecins Sans Frontières (MSF) calls upon governments in the Americas to guarantee access to medicines for people across the continent.

More >

Pages